The effects of 5-fluorouracil alone and in combination with 13-cis retinoic acid and vitamin D3 on human oral squamous cell carcinoma lines.

AIM Oral squamous cell carcinoma (OSCC) is responsible for about 90% of oral malignancies and its incidence is increasing. Despite various treatment protocols, survival rate of OSCC is low. Chemotherapy that is used for treating this carcinoma in advanced stages is systemic therapy that destroys carcinogenic cells, and controls tumor metastasis. Chemotherapy is very toxic and has limitations, especially for patients in advanced stages. Considering positive effects of retinoid and vitamin D3 derivatives in treating some carcinomas, we decided to evaluate the effect of combination of these drugs on OSCC. In this study the effects of combination of 5-fluorouracil, 13-cis retinoic acid and vitamin D3 on cultured cell of OSCC have been evaluated. MATERIALS AND METHODS OSCC cells were cultured in culture media and different concentration of 5-fluorouracil, 13-cis retinoic acid and vitamin D3 were added to cultured cell as separately and in combinations. The effect of treatment on cell proliferation and induction of apoptosis were evaluated by MTT and TUNEL assays respectively. RESULTS Combination of 5-fluorouracil and 13- cis retinoic acid had the highest inhibitory effect on SCC cell proliferation. Combination of two drugs had more apoptotic effect than each of them separately, and combination of three drugs had more effect than combination of two drugs. CONCLUSION Because combination of drugs had more inhibitory effect on cell proliferation than one of them and combination of three drugs had the most apoptotic effect than one of these drugs separately, these drugs may have synergic effect on OSCC. CLINICAL SIGNIFICANCE Combination of three drugs has more inhibitory effect on cell proliferation and apoptotic effect than one of these drugs.

[1]  L. Gudas,et al.  A DNA Methyltransferase Inhibitor and All-trans Retinoic Acid Reduce Oral Cavity Carcinogenesis Induced by the Carcinogen 4-Nitroquinoline 1-Oxide , 2009, Cancer Prevention Research.

[2]  C. la Vecchia,et al.  Dietary vitamin D and cancers of the oral cavity and esophagus. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Zhi-Yuan Zhang,et al.  Combined and sequential treatment of oral and maxillofacial malignancies: an evolving concept and clinical protocol. , 2008, Chinese Medical Journal.

[4]  P. Hershberger,et al.  1α,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model , 2008, Molecular Cancer Therapeutics.

[5]  Ping Zhang,et al.  Antisense oligonucleotides and all-trans retinoic acid have a synergistic anti-tumor effect on oral squamous cell carcinoma , 2008, BMC Cancer.

[6]  J. Albala,et al.  Treatment with 1-alpha,25-dihydroxyvitamin D3 (vitamin D3) to inhibit carcinogenesis in the hamster buccal pouch model. , 2007, Archives of otolaryngology--head & neck surgery.

[7]  C. Abnet,et al.  Serum 25(OH)-Vitamin D Concentration and Risk of Esophageal Squamous Dysplasia , 2007, Cancer Epidemiology Biomarkers & Prevention.

[8]  H. Fujii,et al.  Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma , 2007, British Journal of Cancer.

[9]  F. Khuri,et al.  Induction of cell cycle arrest and apoptosis by a combined treatment with 13‐cis‐retinoic acid, interferon‐α2a, and α‐tocopherol in squamous cell carcinoma of the head and neck , 2007 .

[10]  B. Foster,et al.  Antitumor Effects of Two Less-Calcemic Vitamin D Analogs (Paricalcitol and QW-1624F2-2) in Squamous Cell Carcinoma Cells , 2007, Oncology.

[11]  M. Weissenboeck,et al.  1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[12]  R. Ralhan,et al.  Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: Relationship with cell cycle regulators , 2006, International journal of cancer.

[13]  T. Seiwert,et al.  State-of-the-art management of locally advanced head and neck cancer , 2005, British Journal of Cancer.

[14]  L. Klein-Hitpass,et al.  WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. , 2005, Haematologica.

[15]  M. Suzui,et al.  Effects of Acyclic Retinoid on Growth, Cell Cycle Control, Epidermal Growth Factor Receptor Signaling, and Gene Expression in Human Squamous Cell Carcinoma Cells , 2004, Clinical Cancer Research.

[16]  J. Sudbø,et al.  RETRACTED: Molecular based treatment of oral cancer , 2003 .

[17]  J. Sudbø,et al.  Molecular based treatment of oral cancer. , 2003, Oral oncology.

[18]  S. Bruno,et al.  Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment. , 2002, Carcinogenesis.

[19]  D. Trump,et al.  Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells. , 2002, Endocrinology.

[20]  P. Hershberger,et al.  Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  C. Gavaldá,et al.  Retinoids: application in premalignant lesions and oral cancer. , 2001, Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal.

[22]  I. Lung,et al.  In vitro inhibition of head and neck cancer-cell growth by human recombinant interferon-alpha and 13-cis retinoic acid. , 2001, British Journal of Biomedical Science.

[23]  D. Thurnher,et al.  1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. , 2001, Acta oto-laryngologica.

[24]  C. Van Waes,et al.  Inhibition of transcription factor nuclear factor-κB by a mutant inhibitor-κBα attenuates resistance of human head and neck squamous cell carcinoma to TNF-α caspase-mediated cell death , 2000, British Journal of Cancer.

[25]  Gorospe,et al.  17. Utility of Metabolic Imaging in Oral Squamous Cell Carcinoma (SCC) Staging. Experience in 30 Patients. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[26]  B. Conley,et al.  Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  J. White,et al.  The independent and combined effects of RAR-, RXR-, and VDR-selective ligands on the growth of squamous cell carcinoma in vitro. , 1999, The Journal of otolaryngology.

[28]  N. Bouck,et al.  Retinoic Acid and Interferon α Act Synergistically as Antiangiogenic and Antitumor Agents against Human Head and Neck Squamous Cell Carcinoma , 1998 .

[29]  N. Bouck,et al.  Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. , 1998, Cancer research.

[30]  Wei-dong Yu,et al.  Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. , 1997, Cancer research.

[31]  D. Bikle,et al.  Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor. , 1996, The Journal of investigative dermatology.

[32]  J. Hayes,et al.  Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  S. Hong,et al.  Calcipotriol (MC 903), a synthetic derivative of vitamin D3 stimulates differentiation of squamous carcinoma cell line in the raft culture. , 1996, Anticancer research.

[34]  T. Chou,et al.  Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: A rationale for combination therapy with chemotherapeutic agents , 1995, International journal of cancer.

[35]  Lin Hs,et al.  In vitro inhibition of prostaglandin biosynthesis in squamous cell carcinoma by retinoids. , 1990 .

[36]  T. Elattar,et al.  In vitro inhibition of prostaglandin biosynthesis in squamous cell carcinoma by retinoids. , 1990, Eicosanoids.